Back
Editas Medicine, Inc. EDIT · Insights
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative... Price2.75
Market Cap427.92 M
Float154.83 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro